Copyright
©The Author(s) 2023.
World J Gastrointest Endosc. Mar 16, 2023; 15(3): 177-190
Published online Mar 16, 2023. doi: 10.4253/wjge.v15.i3.177
Published online Mar 16, 2023. doi: 10.4253/wjge.v15.i3.177
Figure 1 PRISMA flow charts.
A: Flowsheet diagram demonstrating inclusion of studies for meta-analysis of endoscopic radiofrequency ablation (ERFA) with stenting versus biliary stenting alone; B: Flowsheet diagram demonstrating inclusion of studies for meta-analysis of ERFA with stenting versus photodynamic therapy with stenting. CCA: Cholangiocarcinoma; PDT: Photodynamic therapy.
Figure 2 Forest plot of mean stent survival among treatment groups along with difference in survival.
RFA: Radiofrequency ablation.
Figure 3 Kaplan-Meier survival curve of endoscopic radiofrequency ablation with stenting vs stenting alone.
ERFA: Endoscopic radiofrequency ablation.
Figure 4 Forest plot of mean survival of endoscopic radiofrequency ablation with stenting; percutaneous radiofrequency ablation with stenting; comparisons to corresponding biliary stenting alone subgroups; and overall comparisons in mean survival.
ERFA: Endoscopic radiofrequency ablation; PRFA: Percutaneous radiofrequency ablation.
Figure 5 Kaplan-Meier survival curve of endoscopic radiofrequency ablation and percutaneous radiofrequency ablation with stenting compared to biliary stenting alone.
ERFA: Endoscopic radiofrequency ablation; PRFA: Percutaneous radiofrequency ablation.
Figure 6 Kaplan-Meier survival curve of endoscopic radiofrequency ablation with stenting compared to photodynamic therapy with stenting.
RFA: Radiofrequency ablation; PDT: Photodynamic therapy.
- Citation: Rebhun J, Shin CM, Siddiqui UD, Villa E. Endoscopic biliary treatment of unresectable cholangiocarcinoma: A meta-analysis of survival outcomes and systematic review. World J Gastrointest Endosc 2023; 15(3): 177-190
- URL: https://www.wjgnet.com/1948-5190/full/v15/i3/177.htm
- DOI: https://dx.doi.org/10.4253/wjge.v15.i3.177